Deborah Collyar

Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)

William M. Sikov, Donald A. Berry, Charles M. Perou et al. · Journal of Clinical Oncology · 2014 · 1K citations · Full text

Medicine, Oncology, Pharmacology +17

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update

Ian E. Krop, Nofisat Ismaila, Fabrice André et al. · Journal of Clinical Oncology · 2017 · 316 citations · Full text

Medicine, Oncology, Breast Oncology +16

The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)

E. Shelley Hwang, Terry Hyslop, Thomas Lynch et al. · BMJ Open · 2019 · 307 citations · Full text

Medicine, Oncology, Surgery +14

American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction

Kala Visvanathan, Rowan T. Chlebowski, Patricia A. Hurley et al. · Journal of Clinical Oncology · 2009 · 289 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update—Integration of Results From TAILORx

Fabrice André, Nofisat Ismaila, N. Lynn Henry et al. · Journal of Clinical Oncology · 2019 · 231 citations · Full text

Medicine, Endocrinology, Oncology +17